Cargando…

Quantifying the natural history of breast cancer

BACKGROUND: Natural history models of breast cancer progression provide an opportunity to evaluate and identify optimal screening scenarios. This paper describes a detailed Markov model characterising breast cancer tumour progression. METHODS: Breast cancer is modelled by a 13-state continuous-time...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, K H X, Simonella, L, Wee, H L, Roellin, A, Lim, Y-W, Lim, W-Y, Chia, K S, Hartman, M, Cook, A R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798948/ https://www.ncbi.nlm.nih.gov/pubmed/24084766 http://dx.doi.org/10.1038/bjc.2013.471

Ejemplares similares

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
por: Park, Y H, et al.
Publicado: (2009)

Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients
por: Lim, S-T, et al.
Publicado: (2005)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005)

The Natural History of Globus Pharyngeus
por: Cashman, E. C., et al.
Publicado: (2010)

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
por: Lim, S H, et al.
Publicado: (2015)

Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial
por: Yang, H, et al.
Publicado: (2013)

Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial
por: Chu, E, et al.
Publicado: (2014)

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
por: Ahn, H K, et al.
Publicado: (2013)

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
por: Toh, C-K, et al.
Publicado: (2005)

Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma
por: Chow, P K H, et al.
Publicado: (2011)

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity
por: Kim, K-p, et al.
Publicado: (2011)

Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract
por: Ault, Kevin A.
Publicado: (2006)

Natural history of age-related lobular involution and impact on breast cancer risk
por: Radisky, Derek C., et al.
Publicado: (2016)

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
por: Zhang, B, et al.
Publicado: (2013)

S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study
por: Wang, X, et al.
Publicado: (2018)

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum
por: Yi, J H, et al.
Publicado: (2012)

The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform
por: Chong, M-h, et al.
Publicado: (2012)

Spectrum of very early breast cancer in a setting without organised screening
por: Bhoo-Pathy, N, et al.
Publicado: (2014)

Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China
por: Cao, D Y, et al.
Publicado: (2013)

The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease
por: Wolff, Anette Boe, et al.
Publicado: (2021)

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
por: Zhao, X-Y, et al.
Publicado: (2014)

Prostate cancer as a first and second cancer: effect of family history
por: Zhang, H, et al.
Publicado: (2009)

Circulating levels of leptin, adiposity and breast cancer risk
por: Wu, M-H, et al.
Publicado: (2009)

The Natural History and Outcomes of the Patients with Carcinosarcoma Involving Kidney and Renal Pelvis
por: Wang, Jue, et al.
Publicado: (2011)

The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study
por: Tang, L-Q, et al.
Publicado: (2014)

A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
por: Sakiyama, T, et al.
Publicado: (2015)

Mammographic screening for young women with a family history of breast cancer: knowledge and views of those at risk
por: Tyndel, S, et al.
Publicado: (2008)

Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05)
por: Noh, J M, et al.
Publicado: (2014)

Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk
por: Ahern, C H, et al.
Publicado: (2014)

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
por: Yeh, K H, et al.
Publicado: (2005)

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
por: Chao, Y, et al.
Publicado: (2006)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
por: Miles, D W, et al.
Publicado: (2013)

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors
por: Zeng, L, et al.
Publicado: (2014)

Human papillomavirus detected in female breast carcinomas in Japan
por: Khan, N A, et al.
Publicado: (2008)

Mannan-Binding Lectin Levels and Activity Are Not Altered in Atopic Dermatitis Patients with a History of Eczema Herpeticum
por: Bundy, Kemp W., et al.
Publicado: (2011)

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
por: Iwase, H, et al.
Publicado: (2013)

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
por: Yang, J J, et al.
Publicado: (2017)

Soybean products and reduction of breast cancer risk: a case–control study in Japan
por: Hirose, K, et al.
Publicado: (2005)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0v47mi1ff7e8dfq4oi4n1sb1u4